文献速递神经儿科影像MR

儿童弥漫性内生性脑桥胶质瘤的分子与突变分析的MR成像相关因素

MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-05-07

本研究分析50例弥漫性内生性脑桥胶质瘤患儿治疗前MRI,按EGFR和MGMT突变分为4个分子亚组,并检测组蛋白突变;结果显示强化肿瘤体积、ADC直方图参数在分子亚组及H3F3A与HIST1H3B/C突变间存在差异,提示MR特征与分子分型相关。

要点

  • 强化肿瘤体积在分子亚组间差异接近显著(P=.04),经错误发现率校正后。
  • H3F3A与HIST1H3B/C突变患儿间强化体积及ADC中位数、众数、偏度、峰度显著不同(P≤.048)。
  • ADC直方图参数和强化特征有助于提示弥漫性内生性脑桥胶质瘤的分子亚型。

关键影像表现/征象

  • 分析指标包括基于FLAIR的FLAIR/T2肿瘤体积、强化肿瘤体积、囊变和/或坏死存在与否、基于FLAIR的ADC肿瘤体积的中位数、均值、众数、偏度、峰度及基线强化。

诊断标准与关键数值

  • 分子亚组基于EGFR和MGMT突变建立:MGMT-/EGFR- 28例、MGMT-/EGFR+ 14例、MGMT+/EGFR- 3例、MGMT+/EGFR+ 3例。
  • 组蛋白突变:H3F3A 23例、HIST1H3B 8例、HIST1H3C 3例。
  • 强化肿瘤体积在分子亚组间差异接近显著(P=.04),经错误发现率校正后。
  • H3F3A与HIST1H3B/C突变患者间强化肿瘤体积及ADC T2-FLAIR/T2的中位数、众数、偏度、峰度显著不同(P≤.048)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Recent advances in molecular techniques have characterized distinct subtypes of diffuse intrinsic pontine gliomas. Our aim was the identification of MR imaging correlates of these subtypes.

MATERIALS AND METHODS: Initial MRIs from subjects with diffuse intrinsic pontine gliomas recruited for a prospective clinical trial before treatment were analyzed. Retrospective imaging analyses included FLAIR/T2 tumor volume, tumor volume enhancing, the presence of cyst and/or necrosis, median, mean, mode, skewness, kurtosis of ADC tumor volume based on FLAIR, and enhancement at baseline. Molecular subgroups based on EGFR and MGMT mutations were established. Histone mutations were also determined (H3F3A, HIST1H3B, HIST1H3C). Univariate Cox proportional hazards regression was used to test the association of imaging predictors with overall and progression-free survival. Wilcoxon rank sum, Kruskal-Wallis, and Fisher exact tests were used to compare imaging measures among groups.

RESULTS: Fifty patients had biopsy and MR imaging. The median age at trial registration was 6 years (range, 3.3-17.5 years); 52% were female. On the basis of immunohistochemical results, 48 patients were assigned to 1 of 4 subgroups: 28 in MGMT-/epidermal growth factor receptor (EGFR)-, 14 in MGMT-/EGFR+, 3 in MGMT+/EGFR-, and 3 in MGMT+/EGFR+. Twenty-three patients had histone mutations in H3F3A, 8 in HIST1H3B, and 3 in HIST1H3C. Enhancing tumor volume was near-significantly different across molecular subgroups (P = .04), after accounting for the false discovery rate. Tumor volume enhancing, median, mode, skewness, and kurtosis ADC T2-FLAIR/T2 were significantly different (P ≤ .048) between patients with H3F3A and HIST1H3B/C mutations.

CONCLUSIONS: MR imaging features including enhancement and ADC histogram parameters are correlated with molecular subgroups and mutations in children with diffuse intrinsic pontine gliomas.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Jaimes C, Vajapeyam S, Brown D, et al. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma. AJNR Am J Neuroradiol. 2020. PMID: 32381545. doi:10.3174/ajnr.A6546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。